United Biomedical Inc

United Biomedical Inc. (UBI) is a privately held multinational biopharmaceutical company based in Hauppauge, New York. The company employs 45 people and generates over $10,000 in annual revenue. UBI is dedicated to the discovery, development, and commercialization of immunotherapeutics and vaccines. UBI's product pipeline is focused on developing synthetic peptide-based biologicals for a variety of applications. These include treatments and prevention strategies for Alzheimer’s Disease, AIDS, and Allergy, as well as animal health diseases. The company utilizes proprietary designer peptides, vaccine formulation systems, and methods for manufacturing therapeutic monoclonal antibodies. Additionally, UBI leverages its platform technologies to develop biosimilar versions of protein and antibody drugs nearing patent expiration. Beyond its core therapeutic focus, UBI has successfully commercialized a synthetic peptide vaccine and utilizes its proprietary designer peptide technology to produce blood screening diagnostics. The company also generates revenue through pharmaceutical contract manufacturing by its subsidiary, UBI-Asia, and various product development sponsorships. Interested parties can learn more about United Biomedical Inc. by visiting their website at unitedbiomedical.com.